RenaSci is pleased to announce that David Heal, one of our Directors, has recently been elected to become a Member of the American College of Neuropsychopharmacology. The ACNP is a professional organisation of leading neuroscientists and psychiatrists from academia and the pharmaceutical industry. David was awarded his membership to this prestigious scientific society in recognition of his contribution to the field of neuropsychopharmacology including innovative research into mechanisms of CNS drug action and the development of better models for assessing drug abuse liability. His election to ACNP also reflects his achievements during his tenure in the pharmaceutical industry and at RenaSci in facilitating the discovery and development of more than 10 new drugs to treat CNS disorders.
For more details or information on how we can support your project please complete the contact form.